参考文献/References:
[1] VAN LOON K, ZHANG L, KEISER J, et al. Bone metastases and skeletal-related events from neuroendocrine tumors [J]. Endocr Connect, 2015, 4(1): 9-17.
[2] PAVEL M, BAUDIN E, COUVELARD A, et al. ENETS Consensus Guidelines for the management of patients with liver and other distant metastases from neuroendocrine neoplasms of foregut, midgut, hindgut, and unknown primary [J]. Neuroendocrinology, 2012, 95 (2): 157-76.
[3] KLIMSTRA DS, MODLIN IR, COPPOLA D, et al. The pathologic classification of neuroendocrine tumors: a review of nomenclature, grading, and staging systems [J]. Pancreas, 2010, 39(6): 707-712.
[4] LI C, HUANG J, YANG X, et al. A primary neuroendocrine tumor of the left ventricle presenting with diarrhea-an unusual experience and literature review [J]. Diagn Pathol, 2020, 15(1): 32.
[5] DASARI A, SHEN C, HALPERIN D, et al. Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States [J]. JAMA Oncol, 2017, 3(10): 13351342.
[6] COSTANZO R, PORZIO M, GERARDI RM, et al. Thoracic dumbbell spinal metastasis secondary to neuroendocrine tumor of unknown origin: case report and literature review [J]. Surg Neurol Int, 2022, 13: 199.
[7] CHEN C, NOTKINS AL, LAN MS. Insulinoma-associated-1: from neuroendocrine tumor marker to cancer therapeutics [J]. Mol Cancer Res, 2019, 17(8): 1597-604.